Page 1 of Clinical Trials for Lymphoproliferative malignancies, 4861 Total Matches
- 1CompletedLast Updated: January 16, 2012Condition(s): Relapsed or Refractory Lymphoproliferative Malignancies; Hodgkin's Lymphoma; Peripheral T-cell Lymphoma; B-cell Lymphoma; Waldenstrom's Macroglobulinemia
- 2RecruitingLast Updated: February 17, 2012Condition(s): Non-Hodgkin's Lymphoma; Hodgkin's Disease; Leukemia, Lymphocytic, Chronic; Lymphoproliferative Disorders
- 3RecruitingLast Updated: November 14, 2011Condition(s): Relapsed and Refractory Acute Leukemia
- 4Active, not recruitingIrinotecan in Treating Patients With Newly Diagnosed or Relapsed Non- Hodgkin's Lymphoma or LeukemiaLast Updated: July 23, 2008Condition(s): Leukemia; Lymphoma
- 5RecruitingLast Updated: October 31, 2011Condition(s): Stem Cell Leukemia of Unclear Lineage; Graft Versus Host Disease
- 6RecruitingLast Updated: May 4, 2011Condition(s): Chronic Lymphocytic Leukemia
- 7RecruitingLast Updated: March 22, 2011Condition(s): Leukemia; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
- 8TerminatedLast Updated: July 28, 2011Condition(s): Lymphoid Malignancies; Lymphoproliferative Disorders
- 9RecruitingLast Updated: May 8, 2012Condition(s): Lymphoma; Leukemia; Multiple Myeloma; Colon Cancer; Renal Cancer
- 10CompletedLast Updated: June 23, 2005Condition(s): Sarcoma, Kaposi; HIV Infections; Lymphoproliferative Disorders
- 11Active, not recruitingLast Updated: February 6, 2009Condition(s): Gastric Cancer; Head and Neck Cancer; Lymphoma; Lymphoproliferative Disorder
- 12RecruitingLast Updated: March 22, 2012Condition(s): Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
- 13CompletedLast Updated: December 16, 2009Condition(s): Leukemia; Lymphoma; Lymphoproliferative Disorder
- 14CompletedLast Updated: January 27, 2010Condition(s): Leukemia; Lymphoma; Precancerous Condition; Small Intestine Cancer
- 15Active, not recruitingLast Updated: August 10, 2011Condition(s): Chronic Myeloproliferative Disorders; Fatigue; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Precancerous Condition; Unspecified Adult Solid Tumor, Protocol Specific
- 16RecruitingLast Updated: April 23, 2012Condition(s): Non-Hodgkin's Lymphoma; Epstein-Barr Virus
- 17Active, not recruitingLast Updated: December 1, 2011Condition(s): Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Kidney Cancer; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Nonneoplastic Condition; Unspecified Adult Solid Tumor, Protocol Specific
- 18Active, not recruitingLast Updated: November 9, 2010Condition(s): Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Pain; Precancerous Condition; Unspecified Adult Solid Tumor, Protocol Specific
- 19WithdrawnLast Updated: December 8, 2011Condition(s): Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Nonmalignant Neoplasm; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
- 20RecruitingLast Updated: May 23, 2012Condition(s): Brain and Central Nervous System Tumors; Lymphoma; Lymphoproliferative Disorder; Small Intestine Cancer; Unspecified Childhood Solid Tumor, Protocol Specific
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Lymphoproliferative+malignancies
